Platform Clinical Study for Conquering Scleroderma

Conditions: Interstitial Lung Disease Due to Systemic Disease; Scleroderma Interventions: Drug: Amlitelimab; Drug: BI 1015550; Drug: Placebo Sponsors: Scleroderma Research Foundation, Inc.; Sanofi; Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials